Metraipolis › archive › dc_e46702f0cf32

Long-term treatment outcomes of upadacitinib for Crohn's disease: a single-center retrospective study — Europe PMC PMID:42293308

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42293308
DOI
10.1093/crocol/otag047
License (as archived)
solo-consultazione
Archived
2026-11-03T13:17:21.683Z
SHA-256 of the archived text
527842ca5d840b330dabc291015af432ae3899a2decc31cb2f7a38a1783c6bb6
Stable URL of this page
https://metraipolis.com/documento/dc_e46702f0cf32

How to cite

Long-term treatment outcomes of upadacitinib for Crohn's disease: a single-center retrospective study — Europe PMC PMID:42293308 — Europe PMC (en), https://europepmc.org/article/MED/42293308 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e46702f0cf32 (Metraipolis archive dc_e46702f0cf32, sha256 527842ca5d840b330dabc291015af432ae3899a2decc31cb2f7a38a1783c6bb6)
BibTeX
@misc{dce46702f0cf32,
  title = {Long-term treatment outcomes of upadacitinib for Crohn's disease: a single-center retrospective study — Europe PMC PMID:42293308},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42293308},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e46702f0cf32; sha256 527842ca5d840b330dabc291015af432ae3899a2decc31cb2f7a38a1783c6bb6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42293308. Agents can read the archived copy with the MCP tool read_document.